Table 2 Pathways significantly enriched in MCS

Thyroid hormone synthesis

ko04918

0.00023872

Two-component system

ko02020

0.00123756

Antimicrobial resistance genes

ko01504

0.0015079

Endocytosis

ko04144

0.00151049

Xylene degradation

ko00622

0.00195105

Cationic antimicrobial peptide resistance

ko01503

0.00406715

Arachidonic acid metabolism

ko00590

0.00543367

Two-component system

ko02022

0.00719206

Glycan metabolism

0.00847242

Dioxin degradation

ko00621

0.01358711

MicroRNAs in cancer

ko05206

0.01358711

Huntington disease

ko05016

0.01660993

Chromosome and associated proteins

ko03036

0.02019539

Steroid biosynthesis

ko00100

0.02218133

Prokaryotic defense system

ko02048

0.02222404

Cholesterol metabolism

ko04979

0.02330197

Human T-cell leukemia virus 1 infection

ko05166

0.02330197

Neuroactive ligand-receptor interaction

ko04080

0.02330197

beta-Lactam resistance

ko01501

0.02330197

Glycosyltransferases

ko01003

0.03216668

Sulfur metabolism

ko00920

0.03363934

Protein kinases

ko01001

0.03363934

Cardiac muscle contraction

ko04260

0.04494874

Non-alcoholic fatty liver disease

ko04932

0.04494874

Parkinson disease

ko05012

0.04494874

Mannose type O-glycan biosynthesis

ko00515

0.04758114